FR2685332B1 - - Google Patents

Info

Publication number
FR2685332B1
FR2685332B1 FR9115856A FR9115856A FR2685332B1 FR 2685332 B1 FR2685332 B1 FR 2685332B1 FR 9115856 A FR9115856 A FR 9115856A FR 9115856 A FR9115856 A FR 9115856A FR 2685332 B1 FR2685332 B1 FR 2685332B1
Authority
FR
France
Prior art keywords
alkyl
hydrogen
methylene
compounds
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9115856A
Other languages
English (en)
French (fr)
Other versions
FR2685332A1 (fr
Inventor
Andre Claussner
Francois Nique
Jean-Georges Teutsch
Patrick Van De Velde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR9115856A priority Critical patent/FR2685332A1/fr
Priority to IL104105A priority patent/IL104105A/xx
Priority to ES93902339T priority patent/ES2115754T3/es
Priority to DK93902339T priority patent/DK0623140T3/da
Priority to PCT/FR1992/001193 priority patent/WO1993013123A1/fr
Priority to KR1019940702134A priority patent/KR100278465B1/ko
Priority to RU94031162/04A priority patent/RU2111213C1/ru
Priority to JP51147893A priority patent/JP3445271B2/ja
Priority to AT93902339T priority patent/ATE165365T1/de
Priority to HU9402134A priority patent/HU221482B/hu
Priority to US08/244,735 priority patent/US6281204B1/en
Priority to AU33570/93A priority patent/AU666916B2/en
Priority to CA002124339A priority patent/CA2124339C/fr
Priority to NZ246624A priority patent/NZ246624A/en
Priority to DE69225243T priority patent/DE69225243T2/de
Priority to EP93902339A priority patent/EP0623140B1/fr
Priority to ZA929859A priority patent/ZA929859B/xx
Priority to MX9207421A priority patent/MX9207421A/es
Priority to CN92115248A priority patent/CN1036718C/zh
Publication of FR2685332A1 publication Critical patent/FR2685332A1/fr
Priority to FI942944A priority patent/FI114866B/fi
Application granted granted Critical
Publication of FR2685332B1 publication Critical patent/FR2685332B1/fr
Priority to US09/891,433 priority patent/US6596885B2/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9115856A 1991-12-20 1991-12-20 Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. Granted FR2685332A1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR9115856A FR2685332A1 (fr) 1991-12-20 1991-12-20 Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
IL104105A IL104105A (en) 1991-12-20 1992-12-15 19-nor steroids having a thiocarbon chain in position 11-beta, their preparation and pharmaceutical compositions containing them
NZ246624A NZ246624A (en) 1991-12-20 1992-12-17 Sulphur-containing 11-substituted 19-nor steroids and medicaments
PCT/FR1992/001193 WO1993013123A1 (fr) 1991-12-20 1992-12-17 Nouveaux 19-nor steroides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions
KR1019940702134A KR100278465B1 (ko) 1991-12-20 1992-12-17 11베타 위치에 티오탄산화 사슬이 있는 신규한 19-노르 스테로이드, 그 제조방법, 중간체, 의약으로서의 용도 및 조성물
RU94031162/04A RU2111213C1 (ru) 1991-12-20 1992-12-17 Производные 19-норстероидов, способы их получения, фармацевтическая композиция и промежуточные соединения
JP51147893A JP3445271B2 (ja) 1991-12-20 1992-12-17 １１β位置にチオカーボネート鎖を有する新規の１９−ノルステロイド，その製造方法及びこの方法の中間体，その薬剤としての使用並びに組成物
AT93902339T ATE165365T1 (de) 1991-12-20 1992-12-17 Neue 19-nor steroide, die an der 11-beta stelle an eine thiokohlenstoffgruppe gebunden sind, ein verfahren zu ihrer herstellung und zwischenprodukte dazu
HU9402134A HU221482B (en) 1991-12-20 1992-12-17 New 19-nor steroids, process for producing them, pharmaceutical compositions containing them and intermediates
US08/244,735 US6281204B1 (en) 1991-12-20 1992-12-17 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions
ES93902339T ES2115754T3 (es) 1991-12-20 1992-12-17 Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena tiocarbonada, su procedimiento de preparacion y los productos intermedios de este procedimiento, su aplicacion como medicamentos y composiciones.
CA002124339A CA2124339C (fr) 1991-12-20 1992-12-17 Nouveaux 19-nor steroides ayant en position 11 beta une chaine thiocarbonee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments etles compositions
DK93902339T DK0623140T3 (da) 1991-12-20 1992-12-17 Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der
DE69225243T DE69225243T2 (de) 1991-12-20 1992-12-17 Neue 19-nor steroide, die an der 11-beta stelle an eine thiokohlenstoffgruppe gebunden sind, ein verfahren zu ihrer herstellung und zwischenprodukte dazu
EP93902339A EP0623140B1 (fr) 1991-12-20 1992-12-17 Nouveaux 19-nor steroides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions
AU33570/93A AU666916B2 (en) 1991-12-20 1992-12-17 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids
ZA929859A ZA929859B (en) 1991-12-20 1992-12-18 19-nor steroids having a thiocarbon chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
MX9207421A MX9207421A (es) 1991-12-20 1992-12-18 Nuevos 19-nor-esteroides que tienen en la posicion 11 beta una cadena tiocarbonada, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
CN92115248A CN1036718C (zh) 1991-12-20 1992-12-19 在11β位是有硫碳链的19-去甲留淡化合物的制备方法
FI942944A FI114866B (fi) 1991-12-20 1994-06-17 Menetelmä 19-nor-estratrieenisteroidien valmistamiseksi, joilla on tiohiiliketju 11beta asemassa
US09/891,433 US6596885B2 (en) 1991-12-20 2001-06-26 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115856A FR2685332A1 (fr) 1991-12-20 1991-12-20 Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Publications (2)

Publication Number Publication Date
FR2685332A1 FR2685332A1 (fr) 1993-06-25
FR2685332B1 true FR2685332B1 (enExample) 1995-06-02

Family

ID=9420274

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9115856A Granted FR2685332A1 (fr) 1991-12-20 1991-12-20 Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Country Status (20)

Country Link
US (2) US6281204B1 (enExample)
EP (1) EP0623140B1 (enExample)
JP (1) JP3445271B2 (enExample)
KR (1) KR100278465B1 (enExample)
CN (1) CN1036718C (enExample)
AT (1) ATE165365T1 (enExample)
AU (1) AU666916B2 (enExample)
CA (1) CA2124339C (enExample)
DE (1) DE69225243T2 (enExample)
DK (1) DK0623140T3 (enExample)
ES (1) ES2115754T3 (enExample)
FI (1) FI114866B (enExample)
FR (1) FR2685332A1 (enExample)
HU (1) HU221482B (enExample)
IL (1) IL104105A (enExample)
MX (1) MX9207421A (enExample)
NZ (1) NZ246624A (enExample)
RU (1) RU2111213C1 (enExample)
WO (1) WO1993013123A1 (enExample)
ZA (1) ZA929859B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
DE19526146A1 (de) * 1995-07-07 1997-01-09 Schering Ag Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19724187A1 (de) * 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
HUP9802054A3 (en) * 1997-10-14 2001-02-28 Bayer Ag Process for producing 4,4,5,5,5-pentafluor-1-pentanol
US6548491B2 (en) 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en) 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19826213A1 (de) * 1998-06-09 1999-12-16 Schering Ag Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
DE69902684T2 (de) * 1998-11-20 2003-04-24 Akzo Nobel N.V., Arnheim/Arnhem Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11
DE19929715A1 (de) 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
WO2001040805A1 (en) * 1999-11-30 2001-06-07 Akzo Nobel N.V. Steroid compounds for steroid receptor binding assays
WO2005090379A1 (en) * 2004-03-17 2005-09-29 The Central Science Laboratory, 'csl' Compounds and sensor for detecion of polycyclic aromatic hydrocarbons
EP1623713A1 (en) * 2004-07-09 2006-02-08 Proskelia SAS Cominations of pure anti-estrogen with aromatase inhibitors
EP1630167A1 (en) * 2004-07-09 2006-03-01 Proskelia SAS Polymorphs of 19-Nor steroid derivatives
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
DE102008061722A1 (de) 2008-12-12 2010-06-17 Saltigo Gmbh Verfahren zur Herstellung von Perfluoralkyl- oder Perfluoralkoxyalkanolen
ME03351B (me) 2014-01-29 2019-10-20 Umecrine Cognition Ab Steroidno jedinjenje za upotrebu u lečenju hepatične encefalopatije
AR103384A1 (es) 2015-01-12 2017-05-03 Umecrine Cognition Ab 3a-ETINILO, 3b-HIDROXI, 5a-PREGNAN-20-OXIMA COMO MODULADOR DE GABA
US10278977B2 (en) 2016-06-06 2019-05-07 Umecrine Cognition Ab Methods for treating hypersomnolence
CN110117217B (zh) * 2018-12-19 2021-09-28 浙江普洛家园药业有限公司 1-溴代甲基-2,3,5,6-四氟-4-(三氟甲基)苯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
EP0471612B1 (fr) * 1990-08-14 1998-01-28 Roussel Uclaf Nouveaux 19-Nor stéroides ayant en position 11béta une chaíne carbonée comportant une fonction amide, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Also Published As

Publication number Publication date
NZ246624A (en) 1995-12-21
US6596885B2 (en) 2003-07-22
CN1036718C (zh) 1997-12-17
CA2124339C (fr) 2005-02-15
JP3445271B2 (ja) 2003-09-08
AU666916B2 (en) 1996-02-29
HUT68068A (en) 1995-05-29
HU9402134D0 (en) 1994-09-28
FR2685332A1 (fr) 1993-06-25
JPH07502281A (ja) 1995-03-09
FI942944L (fi) 1994-06-17
HU221482B (en) 2002-10-28
ES2115754T3 (es) 1998-07-01
EP0623140B1 (fr) 1998-04-22
IL104105A0 (en) 1993-05-13
FI114866B (fi) 2005-01-14
KR100278465B1 (ko) 2001-02-01
IL104105A (en) 1997-07-13
AU3357093A (en) 1993-07-28
RU2111213C1 (ru) 1998-05-20
ATE165365T1 (de) 1998-05-15
RU94031162A (ru) 1996-04-20
EP0623140A1 (fr) 1994-11-09
DE69225243T2 (de) 1998-10-29
MX9207421A (es) 1993-07-01
ZA929859B (en) 1993-12-20
FI942944A0 (fi) 1994-06-17
DK0623140T3 (da) 1999-02-15
US20020072624A1 (en) 2002-06-13
CN1075722A (zh) 1993-09-01
US6281204B1 (en) 2001-08-28
CA2124339A1 (fr) 1993-07-08
WO1993013123A1 (fr) 1993-07-08
DE69225243D1 (de) 1998-05-28

Similar Documents

Publication Publication Date Title
FR2685332B1 (enExample)
DE3276368D1 (en) Photopolymerizable compositions, their use in dentistry, and process for preparing dental prostheses, dental fillings, and coatings
HU913793D0 (en) Method for producing new hidantoine compounds
BG101402A (en) Apoliprotein-b synthesis inhibitors
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
AU5965890A (en) New antiviral agents
HU9401427D0 (en) 19-nor steroide derivatives, process for producing them and compositions containing them
DE3767351D1 (de) Sialosylceramide und verfahren zu deren herstellung.
EP0314435A3 (en) Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them
EP0245902A3 (en) Benzothiazinone derivatives
ES469961A1 (es) Procedimiento para la obtencion de nuevos derivados del cro-meno.
ES467027A1 (es) Un procedimiento para preparar eteres de benciloxima.
KR930702378A (ko) 17-β-에스트라디올 유도체, 이것의 제조방법 및 이 화합물을 함유하는 약제
NO902449D0 (no) Fremgangsmaate for fremstilling av p-substituerte propan-fosfinsyre forbindelser.
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES481603A1 (es) Un procedimiento para la preparacion de un derivado de la hidantoina.
EP0308943A3 (en) Agent for regulating the motional function of gastrointestinal tract
ES8307831A1 (es) Procedimiento para preparar nuevos derivados organofosfora- dos.
JPS5610191A (en) Clavulanic acid derivative* its manufacture and composition

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
TP Transmission of property
TP Transmission of property
ST Notification of lapse

Effective date: 20081020